The legacy of Viagra and its impact on the pharmaceutical landscape presents a thorny question for investors . Initially a blockbuster drug, generics have significantly chipped away at its market presence , creating obstacles for companies participating to the original patent holder and subsequent advancements . While certain firms might benefit fr